Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Jan 2025 for Zivo Bioscience, Inc..
Filing timeline
BuySaleNola E. Masterson
Insider track record
Disclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Nola E. Masterson: trading record in brief
Nola E. Masterson (board member) discloses dealings in 2 companies, chiefly Zivo Bioscience, Inc. and Repros Therapeutics Inc. Between 21 November 2016 and 1 January 2025, the trades on record add up to 15 filings.
Market trades split into 2 purchases (€2,383) and 1 sale (€6,089). The net balance comes to €3,706 on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 7 share grants and 3 option exercises.
The newest entry dates from 3 January 2025: a share grant, in Zivo Bioscience, Inc. The most recent open-market purchase was published on 21 December 2022, 1,403 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nola E. Masterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,354 shares0Common StockSEC:0001654954-25-000103:0
6,273 shares0Common StockSEC:0001654954-24-007744:0
30,010 sharesCommon StockSEC:0001654954-24-007463:0
300 shares@ US$2.6418.6% of flowCommon StockSEC:0001654954-22-016814:0
Canonical exit: 19 Mar 2023 (T+90)
400 shares@ US$4.9968.6% of flowCommon StockSEC:0001078782-21-000536:0
Canonical exit: 31 Aug 2021 (T+90)
5 of 5 declarations
